This article was originally published in The Tan Sheet
Introducing two products during the fourth quarter -- a diaper rash product with vitamins A and D, and a zinc oxide product modeled after Pfizer's Desitin. An oral benzocaine gel is planned to debut by early next year. Taro had planned to introduce by the end of 1994 12 OTC cough/cold and analgesic products that would be imported from its manufacturing plant in Israel after GMPs were met ("The Tan Sheet" April 25, p. 15). The diaper rash and zinc oxide products are both made at the firm's Canadian facility
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC